What is Mirum Pharmaceuticals, Inc.'s free cash flow yield?

Mirum Pharmaceuticals, Inc. (MIRM) reported free cash flow yield of -3.1% in Q1 2026.

What is the long-term trend for Mirum Pharmaceuticals, Inc.'s free cash flow yield?

Over 4 years (2020 to 2025), Mirum Pharmaceuticals, Inc.'s free cash flow yield has grown at a -46.7% compound annual growth rate (CAGR), from -16.7% to 1.3%.

What does free cash flow yield mean?

Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.

Mirum Pharmaceuticals, Inc. MIRM Free cash flow yield

Free cash flow yield at other companies

Gilead SciencesGILD

5.9%-1.1pp

Rhythm Pharmaceuticals, Inc.RYTM

-1.6%-0.5pp

Arrowhead ResearchARWR

0.5%+0.3pp

LQD

Liquidia CorporationLQDA

-5.3%-1.9pp

AlkermesALKS

3.8%-5.2pp

Ionis PharmaceuticalsIONS

-11.6%+15.9pp

Other financials

Income statement

See full

Revenue$159.9M+43.3%

Operating income-$789.5M-5,100%

Net income-$790.2M-5,284%

EPS (diluted)-$13.43-4,377%

Balance sheet

See full

Cash & equivalents$261.5M+43.5%

Total debt$13.5M+56.4%

Total equity$242.5M+4.0%

Total assets$890.9M+29.1%

Cash flow

See full

Operating cash flow-$228.8M-11,566%

CapEx$664.0K+1,520%

Free cash flow-$229.4M-11,360%

Valuation

See full

Market cap$6.53B+152%

Enterprise value$6.28B+162%

P/S11.5×+4.6×

Profitability

See full

Operating margin-139.8%-168pp

Net margin-140.2%-169pp

FCF margin-30.3%—

Returns & leverage

See full

Return on equity-335.8%-377pp

Debt / equity0.1×0.0×

Current ratio2.1×-1.1×

Where this comes from

Calculated from Mirum Pharmaceuticals, Inc.’s reported figures.

free cash flow/market cap=-3.1%

Based on trailing twelve months.

The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mirum Pharmaceuticals, Inc.'s free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Mirum Pharmaceuticals, Inc.'s free cash flow yield?: Mirum Pharmaceuticals, Inc. (MIRM) reported free cash flow yield of -3.1% in Q1 2026.
What is the long-term trend for Mirum Pharmaceuticals, Inc.'s free cash flow yield?: Over 4 years (2020 to 2025), Mirum Pharmaceuticals, Inc.'s free cash flow yield has grown at a -46.7% compound annual growth rate (CAGR), from -16.7% to 1.3%.
What does free cash flow yield mean?: Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.